Journal article
Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial: Design and Methods
Abstract
Most patients with type 2 diabetes mellitus develop cardiovascular disease (CVD), with substantial loss of life expectancy. Nonfatal CVD contributes greatly to excess healthcare costs and decreased quality of life in patients with diabetes. The current epidemic of obesity has raised expectations that CVD associated with type 2 diabetes will become an even greater public health challenge. Despite the importance of this health problem, there is a …
Authors
Buse JB; Bigger JT; Byington RP; Cooper LS; Cushman WC; Friedewald WT; Genuth S; Gerstein HC; Ginsberg HN; Goff DC
Journal
The American Journal of Cardiology, Vol. 99, No. 12, pp. s21–s33
Publisher
Elsevier
Publication Date
June 2007
DOI
10.1016/j.amjcard.2007.03.003
ISSN
0002-9149